![Mary Lee Keen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mary Lee Keen
Vertrieb & Marketing bei Bridge Pharmaceuticals, Inc.
Aktive Positionen von Mary Lee Keen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bridge Pharmaceuticals, Inc.
![]() Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. | Vertrieb & Marketing | - | - |
Karriereverlauf von Mary Lee Keen
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Sales & Marketing | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Bridge Pharmaceuticals, Inc.
![]() Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. | Commercial Services |
- Börse
- Insiders
- Mary Lee Keen
- Erfahrung